Muscle hypertrophy has further been observed in children with myostatin mutations [12] and an inverse association between serum myostatin levels and muscle mass has been identified in patients with chronic obstructive pulmonary disease and heart failure [13,14]. Here, MSTN is linked to cardiac hypertrophy.